Li R, Zhang J, Ren L
Adv Respir Med. 2025; 93(1).
PMID: 39996621
PMC: 11852372.
DOI: 10.3390/arm93010004.
Harsoyo P, Ardiana M, Hermawan H, Purnamasari Y, Anandita F
Narra J. 2024; 4(2):e746.
PMID: 39280273
PMC: 11391955.
DOI: 10.52225/narra.v4i2.746.
Zahedipour F, Zahedipour F, Zamani P, Jaafari M, Sahebkar A
Virus Res. 2024; 341:199314.
PMID: 38211734
PMC: 10825633.
DOI: 10.1016/j.virusres.2024.199314.
Loi L, Yang C, Lin Y, Su Y, Juan Y, Chen Y
Heliyon. 2023; 9(12):e22614.
PMID: 38107325
PMC: 10724569.
DOI: 10.1016/j.heliyon.2023.e22614.
Khan N, Kumar N, Geiger J
J Allergy Infect Dis. 2023; 2(3):75-83.
PMID: 37564275
PMC: 10414779.
DOI: 10.46439/allergy.2.028.
Role of Angiotensin II in Cardiovascular Diseases: Introducing Bisartans as a Novel Therapy for Coronavirus 2019.
Swiderski J, Kate Gadanec L, Apostolopoulos V, Moore G, Kelaidonis K, Matsoukas J
Biomolecules. 2023; 13(5).
PMID: 37238657
PMC: 10216788.
DOI: 10.3390/biom13050787.
Efficacy of Plant-Made Human Recombinant ACE2 against COVID-19 in a Golden Syrian Hamster Model.
Kim C, Kim D, Bang M, Seo J, Kim D, Yun N
Viruses. 2023; 15(4).
PMID: 37112944
PMC: 10146983.
DOI: 10.3390/v15040964.
Repeated ethanol exposure and withdrawal alters angiotensin-converting enzyme 2 expression in discrete brain regions: Implications for SARS-CoV-2 neuroinvasion.
Balasubramanian N, James T, Selvakumar G, Reinhardt J, Marcinkiewcz C
Alcohol Clin Exp Res (Hoboken). 2022; 47(2):219-239.
PMID: 36529893
PMC: 9878009.
DOI: 10.1111/acer.15000.
Microalgae as an Efficient Vehicle for the Production and Targeted Delivery of Therapeutic Glycoproteins against SARS-CoV-2 Variants.
Dehghani J, Movafeghi A, Mathieu-Rivet E, Mati-Baouche N, Calbo S, Lerouge P
Mar Drugs. 2022; 20(11).
PMID: 36354980
PMC: 9698596.
DOI: 10.3390/md20110657.
Antiviral potential of diminazene aceturate against SARS-CoV-2 proteases using computational and in vitro approaches.
Santos E, Silva P, Sousa P, Aquino C, Pacheco G, Teixeira L
Chem Biol Interact. 2022; 367:110161.
PMID: 36116513
PMC: 9476334.
DOI: 10.1016/j.cbi.2022.110161.
Multivalent ACE2 engineering-A promising pathway for advanced coronavirus nanomedicine development.
Obeng E, Fianu I, Danquah M
Nano Today. 2022; 46:101580.
PMID: 35942040
PMC: 9350675.
DOI: 10.1016/j.nantod.2022.101580.
Diminazene Aceturate Reduces Angiotensin II Constriction and Interacts with the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2.
Matsoukas J, Kate Gadanec L, Zulli A, Apostolopoulos V, Kelaidonis K, Ligielli I
Biomedicines. 2022; 10(7).
PMID: 35885036
PMC: 9312513.
DOI: 10.3390/biomedicines10071731.
Impact of Hypertension and Physical Fitness on SARS-COV-2 and Related Consequences. (Possible Mechanisms with Focusing on ACE2).
Kushkestani M, Parvani M, Moghadassi M, Kazemzadeh Y, Moradi K
Caspian J Intern Med. 2022; 13(Suppl 3):148-154.
PMID: 35872687
PMC: 9272964.
DOI: 10.22088/cjim.13.0.148.
Drugs Modulating Renin-Angiotensin System in COVID-19 Treatment.
Labandeira-Garcia J, Labandeira C, Valenzuela R, Pedrosa M, Quijano A, Rodriguez-Perez A
Biomedicines. 2022; 10(2).
PMID: 35203711
PMC: 8962306.
DOI: 10.3390/biomedicines10020502.
Soluble Human Angiotensin- Converting Enzyme 2 as a Potential Therapeutic Tool for COVID-19 is Produced at High Levels In Plant With Potent Anti-SARS-CoV-2 Activity.
Mamedov T, Gurbuzaslan I, Yuksel D, Ilgin M, Mammadova G, Ozkul A
Front Plant Sci. 2021; 12:742875.
PMID: 34938305
PMC: 8685454.
DOI: 10.3389/fpls.2021.742875.
COVID-19 and renin angiotensin aldosterone system: Pathogenesis and therapy.
Babajani F, Kakavand A, Mohammadi H, Sharifi A, Zakeri S, Asadi S
Health Sci Rep. 2021; 4(4):e440.
PMID: 34869917
PMC: 8596942.
DOI: 10.1002/hsr2.440.
Predicting respiratory failure in patients infected by SARS-CoV-2 by admission sex-specific biomarkers.
Pagano M, Peruzzu D, Busani L, Pierdominici M, Ruggieri A, Antinori A
Biol Sex Differ. 2021; 12(1):63.
PMID: 34809704
PMC: 8607227.
DOI: 10.1186/s13293-021-00407-x.
Quantifying Renin-Angiotensin-System Alterations in COVID-19.
Pucci F, Annoni F, Dos Santos R, Taccone F, Rooman M
Cells. 2021; 10(10).
PMID: 34685735
PMC: 8535134.
DOI: 10.3390/cells10102755.
Beyond Vaccines: Clinical Status of Prospective COVID-19 Therapeutics.
Kumar S, Caliskan D, Janowski J, Faist A, Conrad B, Lange J
Front Immunol. 2021; 12:752227.
PMID: 34659259
PMC: 8519339.
DOI: 10.3389/fimmu.2021.752227.
Impairment of hypoxic pulmonary vasoconstriction in acute respiratory distress syndrome.
Gierhardt M, Pak O, Walmrath D, Seeger W, Grimminger F, Ghofrani H
Eur Respir Rev. 2021; 30(161).
PMID: 34526314
PMC: 9489056.
DOI: 10.1183/16000617.0059-2021.
